Gankyrin: a novel promising therapeutic target for hepatocellular carcinoma-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

Gankyrin: a novel promising therapeutic target for hepatocellular carcinoma

Published:2017-10-12 Issue:7 Volume:46 Page:1301-1313
ISSN:2169-1401
Container-title:Artificial Cells, Nanomedicine, and Biotechnology
language:en
Short-container-title:Artificial Cells, Nanomedicine, and Biotechnology

Author:

Zamani Parvin¹,Matbou Riahi Maryam¹,Momtazi-Borojeni Amir Abbas²³,Jamialahmadi Khadijeh¹⁴

Affiliation:

1. Department of Medical Biotechnology, Faculty of Medicine, Mashhad University of Medical Sciences, Mashhad, Iran;

2. Nanotechnology Research Center, Bu-Ali Research Institute, Mashhad University of Medical Sciences, Mashhad, Iran;

3. Department of Medical Biotechnology, Student Research Committee, Faculty of Medicine, Mashhad University of Medical Sciences, Mashhad, Iran;

4. Biotechnology Research Center, Mashhad University of Medical Sciences, Mashhad, Iran

Funder

Mashhad University of Medical Sciences

Publisher

Informa UK Limited

Subject

Pharmaceutical Science,Biomedical Engineering,General Medicine,Medicine (miscellaneous),Biotechnology

Link

https://www.tandfonline.com/doi/pdf/10.1080/21691401.2017.1388250

Reference115 articles.

1. Global cancer statistics

2. Davis GL, Dempster J, Meler JD, et al. Hepatocellular carcinoma: management of an increasingly common problem. Proceedings. Dallas, TX: Baylor University Medical Center; 2008.

3. Circulating microRNAs in Hepatocellular Carcinoma: Potential Diagnostic and Prognostic Biomarkers

4. Epidemiology of Hepatocellular Carcinoma

5. Molecular targeted therapy for hepatocellular carcinoma: Current and future

Cited by 24 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Structural modification of the propyl linker of cjoc42 in combination with sulfonate ester and triazole replacements for enhanced gankyrin binding and anti-proliferative activity;Bioorganic & Medicinal Chemistry;2024-08

2. The role of abnormal ubiquitination in hepatocellular carcinoma pathology;Cellular Signalling;2024-02

3. Gankyrin: At the crossroads of cancer diagnosis, disease prognosis, and development of efficient cancer therapeutics;Advances in Cancer Biology - Metastasis;2022-07

4. Second Generation Small Molecule Inhibitors of Gankyrin for the Treatment of Pediatric Liver Cancer;Cancers;2022-06-22

5. Gankyrin has a potential role in embryo implantation via activation of STAT3;Reproduction;2022-03-01

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号京ICP备18003416号-3